Genes vs environment in inflammatory bowel disease: an update

被引:8
|
作者
Dipasquale, Valeria [1 ]
Romano, Claudio [1 ]
机构
[1] Univ Messina, Pediat Gastroenterol & Cyst Fibrosis Unit, Dept Human Pathol Adulthood & Childhood G Barresi, Via Consolare Valeria 1, I-98124 Messina, Italy
关键词
Environment; gene; inflammatory bowel disease; risk factor; very early onset inflammatory bowel disease; CROHNS-DISEASE; ULCERATIVE-COLITIS; PEDIATRIC GASTROENTEROLOGY; WIDE ASSOCIATION; RECENT INSIGHTS; ACTIVE DISEASE; POSITION PAPER; TWIN COHORT; FOLLOW-UP; RISK;
D O I
10.1080/1744666X.2022.2108407
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction Inflammatory bowel diseases (IBDs) are known to be caused by a combination of genetic and environmental factors that vary in their influence on the development of the disease. Environmental exposures seem to influence IBD susceptibility, whereas genetic background is thought to modulate the impact of the environment on disease course and phenotype. Areas covered A broad review of the involvement of genes and the environment in IBD pathogenesis was performed, and information regarding the main genetic and environmental factors - categorized into lifestyle factors, drugs, diet, and microbes - was updated. Monogenic very early onset IBD (VEO-IBD) was also discussed. Expert opinion In the upcoming years, better understanding of gene-environment interactions will contribute to the possibility of a better prediction of disease course, response to therapy, and therapy-related adverse events with the final goal of personalized and more efficient patient management.
引用
收藏
页码:1005 / 1013
页数:9
相关论文
共 50 条
  • [31] Treatment of Inflammatory Bowel Disease in the ElderlyAn Update
    Darrell S. Pardi
    Edward V. Loftus
    Michael Camilleri
    Drugs & Aging, 2002, 19 : 355 - 363
  • [32] Update on inflammatory bowel disease genetics.
    Cho J.
    Current Gastroenterology Reports, 2000, 2 (6) : 434 - 439
  • [33] Update on thiopurine pharmacogenetics in inflammatory bowel disease
    Roberts, Rebecca L.
    Barclay, Murray L.
    PHARMACOGENOMICS, 2015, 16 (08) : 891 - 903
  • [34] Mucin Function in Inflammatory Bowel Disease An Update
    Boltin, Doron
    Perets, Tsachi T.
    Vilkin, Alex
    Niv, Yaron
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (02) : 106 - 111
  • [35] Telemedicine in the Management of Inflammatory Bowel Disease: An Update
    Bhattacharya, Sumona
    Wong, Uni
    Cross, Raymond K.
    SMART HOMECARE TECHNOLOGY AND TELEHEALTH, 2020, 7 : 9 - 17
  • [36] Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update
    O'Sullivan, Shane
    Gilmer, John F.
    Medina, Carlos
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [37] Psychotherapy for inflammatory bowel disease: A review and update
    McCombie, Andrew M.
    Mulder, Roger T.
    Gearry, Richard B.
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (12): : 935 - 949
  • [38] An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
    Thia, Kelvin T.
    Loftus, Edward V., Jr.
    Sandborn, William J.
    Yang, Suk-Kyun
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (12): : 3167 - 3182
  • [39] Update on the treatment of chronic inflammatory bowel disease
    Arnheim, K
    MEDIZINISCHE KLINIK, 1997, 92 (06) : R8 - R8
  • [40] IMMUNOLOGY OF INFLAMMATORY BOWEL-DISEASE - AN UPDATE
    JEWELL, DP
    JOURNAL OF GASTROENTEROLOGY, 1995, 30 : 78 - 82